Premialab

Premialab, based in Hong Kong, founded in 2016, offers advanced portfolio performance and risk analytics for asset owners, managers, and consultants, helping clients navigate investment decisions with precision and clarity. Premialab is a technology-driven firm specializing in portfolio performance and risk analytics solutions. It operates from its headquarters in Hong Kong, servicing clients globally. The founder has extensive experience in the financial technology sector, although specific prior ventures are not detailed.

In December 2025, a consortium co-led by KKR and Balderton Capital invested USD 220 million in Premialab. Premialab provides a sophisticated platform offering portfolio performance and risk analytics, primarily targeting asset owners, asset managers, and consultants. Its core products include an extensive database integrating Morningstar funds, ETFs, systematic strategies, and proprietary benchmarks known as Premialab Pure Factors. This platform enables users to efficiently monitor their investment positions, access granular risk metrics, and evaluate their risk profiles, all from a single interface.

Additionally, the company has partnered with Eurex to facilitate QIS Index futures, enhancing access to systematic strategies through standardized, centrally cleared contracts. Premialab serves a diverse client base across global markets, including regions such as Europe, North America, and Asia-Pacific, supporting various investment strategies through tools that enhance decision-making and optimize portfolio management. Premialab's revenue structure is primarily based on subscription models, where clients pay for access to its robust analytics platform and associated services. Clients, including institutional investors and asset management firms, engage with Premialab to utilize its proprietary tools for performance reporting, risk evaluation, and portfolio construction.

The transactions typically involve tiered pricing plans based on the level of access and features utilized, which may include comprehensive risk reporting and independent price verification. Key offerings like the Premialab Pure Factors® and QIS Index futures serve as flagship products, underpinning the firm's commitment to delivering transparent and actionable insights to its users. In December 2025, a consortium co-led by KKR and Balderton Capital invested USD 220 million in Premialab. The investment will enable the company to accelerate its growth.